Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAn NIH-wide announcement about updated terminology appears above the study page’s 403 error, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe footer revision indicator changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the COSMIC-313 study record. Core study content, including documents and location listings, is no longer visible.SummaryDifference18%

- Check46 days agoChange DetectedThe page’s revision label was updated from v3.6.6 to v3.7.0, indicating a new version of the study record. This update does not alter the study details or user-facing information.SummaryDifference0.0%

- Check60 days agoChange DetectedFooter now displays Revision: v3.6.6, replacing v3.6.5. This represents a minor update to the page's template or content and does not alter study details or functionality.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating an updated version of the study details page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.